Key Players' Offerings in the Cardiotoxicity Screening Market with Recent Development
Explore Company Offerings
| Company | Description |
| Charles River Laboratories | This usually explores a complete set of cardiotoxicity screening services through its Safety Pharmacology & Discovery Services divisions. |
| Labcorp/Covance | Its offerings include in vitro & in-vivo cardiovascular safety, biomarkers, and specialized testing. |
| Eurofins Scientific | Their portfolio assists regulatory compliance (FDA/ICH) and early-stage drug discovery. |
| WuXi AppTec | This facilitates ion channel assessments, stem cell-derived cardiomyocyte platforms, and specialized imaging techniques. |
| Evotec | Its offering comprises integration of human-relevant cell models with advanced analytical technologies. |
| ICON plc | This has explored a "one-stop shop" solution, which combines clinical pharmacology units (CPUs) with an experienced cardiac safety core lab. |
| Certara | A firm emphasizes in silico modeling, simulation, and predictive analytics. |
| Simulations Plus | This provides in silico tools and services for cardiotoxicity screening, especially through its ADMET Predictor & GastroPlus platforms. |
| Axion BioSystems | Its offering focuses on its Maestro multielectrode array (MEA) platform. |
| Multi-Channel Systems (MCS) | This explores the entire set of electrophysiology tools for in vitro and in vivo cardiotoxicity screening. |
Market Forecast
The global cardiotoxicity screening market size was estimated at USD 3.21 billion in 2025 and is predicted to increase from USD 3.59 billion in 2026 to approximately USD 9.61 billion by 2035, expanding at a CAGR of 11.58% from 2026 to 2035.
What are the Key Developments in the Cardiotoxicity Screening Market?
- In January 2026, Cellistic introduced three novel GMP manufacturing platforms to foster iPSC-derived cell therapies across immuno-oncology and regenerative medicine.
- In September 2025, Ncardia launched Ncyte NHP-C vCardiomyocytes to offer a scalable, ethical, and translational tool for cross-species cardiac studies.
Your one-stop hub for detailed Cardiotoxicity Screening Market stats and analysis: Access the Dashboard
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking
